(By Andy Obermueller) Today, I'm going to do something different...
As the chief-investment strategist behind Game-Changing Stocks, I normally spend hours poring over a multitude of newspapers and financial journals to bring my readers the market's next groundbreaking trend.
While this approach has been highly successful, every now and then I like to try something new.
So rather than spending the laborious hours digging through mounds of financial data trying to decipher what will be the "next big thing," I'm going to be looking at where some of the industry's most respected figures -- the insiders -- are parking their cash.
After all, if the CEO of Company X starts buying his stock when it's trading in the proverbial "toilet," then that tells us something about management's long-term expectations for the business...
So, using the Bloomberg Professional Service, I performed a special search function to display all insider trades for the past six months with a market value of more than $1 million. Because stock is often part of an executive's total compensation package, I excluded filings that were made to exercise stock options.
After looking at all the insider buys from the past six months, two companies in particular stood out as potential game-changers...
The first company to make my list was Amyris (Nasdaq: AMRS). Amyris is ultimately a bio-fuel company, but that's not the whole story -- not by a long shot.
The better frame for Amyris is as a "synthetic biology" company. Its scientists use special organisms that are basically little living factories that have been genetically programmed to produce a certain compound.
Right now, the company has its sights set on biofuel, specifically on generating cellulosic ethanol from Brazilian sugarcane.